Modulation of the dose-dependent effects of atropine by low-dose pyridostigmine: Quantification by spectral analysis of heart rate fluctuations in healthy human beings

Shai Izraeli, Menachem Alcalay, Yoav Benjamini, Ruth Wallach-Kapon, Zelig Tochner, Solange Akselrod

Research output: Contribution to journalArticlepeer-review

12 Scopus citations

Abstract

The interaction between a low-dose cholinesterase inhibitor, pyridostigmine (PYR), and atropine was investigated by spectral analysis of heart rate fluctuations in eight healthy humans. Each subject was given increasing boluses of IV atropine during treatment with PYR (30 mg·3/day) or placebo. PYR attenuated the bimodal dose-dependent changes in the respiratory peak (which represents the parasympathetic control) in response to atropine. We suggest that spectral analysis can be used for quantifying the complex dose-dependent cholinergic agonist-antagonist interactions, and may help to disclose an asymptomatic low-dose intoxication with acetylcholinesterase inhibitors.

Original languageEnglish
Pages (from-to)613-617
Number of pages5
JournalPharmacology Biochemistry and Behavior
Volume39
Issue number3
DOIs
StatePublished - Jul 1991
Externally publishedYes

Keywords

  • Anticholinesterase
  • Atropine
  • Humans
  • Pyridostigmine
  • Spectral analysis of heart rate

Fingerprint

Dive into the research topics of 'Modulation of the dose-dependent effects of atropine by low-dose pyridostigmine: Quantification by spectral analysis of heart rate fluctuations in healthy human beings'. Together they form a unique fingerprint.

Cite this